| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9223781 | Annales de Dermatologie et de Vénéréologie | 2005 | 4 Pages |
Abstract
This study confirms the efficacy of low dose thalidomide in the treatment of chronic lupus erythematosus. In our experience, tolerance to this treatment is good, the most frequent side effect was asthenia, but usually mild. No significant peripheral neuropathy was noted. The fear of side effects, notably neurological, should not delay initiation of thalidomide in the case of failure with current treatments.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
A. Brocard, S. Barbarot, B. Milpied, J.-F. Stalder,